Risk of thrombosis in women with malignancies undergoing ovarian stimulation for fertility preservation

Human Reproduction Update

Volumn 20, Issue 6, 2014, Pages 944-951

  Somigliana, Edgardo ^a   Peccatori, Fedro Alessandro ^b   Filippi, Francesca ^a   Martinelli, Fabio ^c   Raspagliesi, Francesco ^c   Martinelli, Ida ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Cancer; Fertility preservation; OHSS; Ovarian hyperstimulation; Thrombosis

Indexed keywords

ARTERY THROMBOSIS; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; DISEASE ASSOCIATION; FEMALE; FERTILITY PRESERVATION; GASTROINTESTINAL TUMOR; HODGKIN DISEASE; HUMAN; LEUKEMIA; NONHODGKIN LYMPHOMA; OVARY CANCER; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PREGNANCY; RISK FACTOR; UTERINE CERVIX CANCER; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; ADVERSE EFFECTS; ANTAGONISTS AND INHIBITORS; FEMALE GENITAL TRACT TUMOR; OOCYTE; OVARIAN HYPERSTIMULATION SYNDROME; PHYSIOLOGY; RISK ASSESSMENT; THROMBOSIS; VENOUS THROMBOSIS;

GONADORELIN; HORMONE ANTAGONIST;

FEMALE; FERTILITY PRESERVATION; GENITAL NEOPLASMS, FEMALE; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; OOCYTES; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; PREGNANCY; RISK ASSESSMENT; THROMBOSIS; VENOUS THROMBOSIS;

EID: 84913596817     PISSN: 13554786     EISSN: 14602369     Source Type: Journal    
DOI: 10.1093/humupd/dmu035     Document Type: Article

References (73)

1. Barcroft J, Dayoub N, Thong KJ. Fifteen year follow-up of embryos cryopreserved in cancer patients for fertility preservation. J Assist Reprod Genet 2013;30: 1407-1413.
2. Bauersachs RM, Manolopoulos K, Hoppe I, Arin MJ, Schleussner E. More on: the 'ART' behind the clot: solving the mystery. J Thromb Haemost 2007;5:438-439.
3. Bedoschi G, Oktay K. Current approach to fertility preservation by embryo cryopreservation. Fertil Steril 2013;99:1496-1502.
4. Bick RL. Cancer-associated thrombosis. N Engl J Med 2003;349:109-111.
5. BlomJW, Doggen CJ, Osanto S,Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 2005;293:715-722.
6. Blom JW, Vanderschoot JP, Oostindiër MJ, Osanto S, van der Meer FJ, Rosendaal FR. Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study. J Thromb Haemost 2006;4:529-535.
7. Brighton TA, Eikelboom JW, Mann K, Mister R, Gallus A, Ockelford P, Gibbs H, Hague W, Xavier D, Diaz R et al.; ASPIRE Investigators. Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med 2012; 367:1979-1987.
8. Budev MM, ArroligaAC, Falcone T. Ovarian hyperstimulation syndrome. Crit Care Med 2005;33(10 Suppl):S301-S306.
9. Caine GJ, Stonelake PS, Lip GY, Kehoe ST. The hypercoagulable state of malignancy: pathogenesis and current debate. Neoplasia 2002;4:465-473.
10. Cakmak H, Rosen MP. Ovarian stimulation in cancer patients. Fertil Steril 2013; 99:1476-1484.
11. Cakmak H, Katz A, Cedars MI, Rosen MP. Effective method for emergency fertility preservation: random-start controlled ovarian stimulation. Fertil Steril 2013; 100:1673-1680.
12. Chan WS. The 'ART' of thrombosis: a review of arterial and venous thrombosis in assisted reproductive technology. Curr Opin Obstet Gynecol 2009;21:207-218.
13. Chan WS, Dixon ME. The 'ART' of thromboembolism: a review of assisted reproductive technology and thromboembolic complications. Thromb Res 2008; 121:713-726.
14. Chan WS,Ginsberg JS. Areviewof upper extremity deep vein thrombosis in pregnancy: unmasking the 'ART' behind the clot. J Thromb Haemost 2006;4:1673-1677.
15. ChewHK, Davies AM,WunT, HarveyD, Zhou H, White RH. The incidence of venous thromboembolism among patients with primary lung cancer. J Thromb Haemost 2008;6:601-608.
16. Chipwete SE, Bugren S, Rafla N. Thrombosis post ovarian hyperstimulation. Fertil Steril 2009;91:1956.e13-14.
17. Cuzick J, Forbes JF, Sestak I, Cawthorn S, Hamed H, Holli K, Howell A; International Breast Cancer Intervention Study I Investigators. Long-term results of tamoxifen prophylaxis for breast cancer-96-month follow-up of the randomized IBIS-I trial. J Natl Cancer Inst 2007;99:272-282.
18. De Stefano V, Sorá F, Rossi E, Chiusolo P, Laurenti L, Fianchi L, Zini G, Pagano L, Sica S, Leone G. The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment. J Thromb Haemost 2005; 3:1985-1992.
19. Donnez J, Dolmans MM, Pellicer A, Diaz-Garcia C, Sanchez Serrano M, Schmidt KT, Ernst E, Luyckx V, Andersen CY. Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation. Fertil Steril 2013;99:1503-1513.
20. Dorais J, Jones K, Hammoud A, Gibson M, Johnstone E, Peterson CM. A superior mesenteric vein thrombosis associated with in vitro fertilization. Fertil Steril 2011; 95:804.e11-13.
21. ESHRE Capri Workshop Group. Venous thromboembolism in women: a specific reproductive health risk. Hum Reprod Update 2013;19:471-482.
22. Estruch R, Ros E, Salas-Salvadó J, Covas MI, Corella D, Arós F, Gómez-Gracia E, Ruiz-Gutiérrez V, Fiol M, Lapetra J et al.; PREDIMED Study Investigators. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 2013;368:1279-1290.
23. Evers JL. Turn, turn, turn. Hum Reprod 2013;28:2313-2314.
24. Fatemi HM, Popovic-Todorovic B, Humaidan P, Kol S, Banker M, Devroey P, García-Velasco JA. Severe ovarian hyperstimulation syndrome after gonadotropinreleasing hormone (GnRH) agonist trigger and 'freeze-all' approach in GnRH antagonist protocol. Fertil Steril 2014;101:1008-1011.
25. Fleming T, Sacks G, Nasser J. Internal jugular vein thrombosis following ovarian hyperstimulation syndrome. Aust N Z J Obstet Gynaecol 2012;52:87-90.
26. Garcia-Velasco JA. Agonist trigger: what is the best approach? Agonist trigger with vitrification of oocytes or embryos. Fertil Steril 2012;97:527-528.
27. Garcia-Velasco JA, Domingo J, Cobo A, Martínez M, Carmona L, Pellicer A. Five years' experience using oocyte vitrification to preserve fertility for medical and nonmedical indications. Fertil Steril 2013;99:1994-1999.
28. Gomes M, Khorana AA. Risk assessment for thrombosis in cancer. Semin Thromb Hemost 2014;40:319-324.
29. Gómez R, Soares SR, Busso C, Garcia-Velasco JA, Simón C, Pellicer A. Physiology and pathology of ovarian hyperstimulation syndrome. Semin Reprod Med 2010;28:448-457.
30. Grossman LC, Michalakis KG, Browne H, Payson MD, Segars JH. The pathophysiology of ovarian hyperstimulation syndrome: an unrecognized compartment syndrome. Fertil Steril 2010;94:1392-1398.
31. Hansen AT, Kesmodel US, Juul S, Hvas AM. No evidence that assisted reproduction increases the risk of thrombosis: a Danish national cohort study. Hum Reprod 2012;27:1499-1503.
32. Hansen AT, Kesmodel US, Juul S, Hvas AM. Increased venous thrombosis incidence in pregnancies after in vitro fertilization. Hum Reprod 2014;29:611-617.
33. Henriksson P,Westerlund E,Wallén H, Brandt L, Hovatta O, Ekbom A. Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilisation: cross sectional study. BMJ 2013;346:e8632.
34. Horsted F, West J, Grainge MJ. Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis. PLoS Med 2012;9:e1001275.
35. Humaidan P, Kol S, Papanikolaou EG; Copenhagen Gn RH Agonist Triggering Workshop Group. GnRH agonist for triggering of final oocyte maturation: time for a change of practice? Hum Reprod Update 2011;17:510-524.
36. Humaidan P, Polyzos NP, Alsbjerg B, Erb K, Mikkelsen AL, Elbaek HO, Papanikolaou EG, Andersen CY. GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients. Hum Reprod 2013; 28:2511-2521.
37. Jacobsen AF, Skjeldestad FE, Sandset PM. Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study. J Thromb Haemost 2008a; 6:905-912.
38. Jacobsen AF, Skjeldestad FE, Sandset PM. Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium-a register-based case-control study. Am J Obstet Gynecol 2008b;198:233.e1-7.
39. Jadoul P, Kim SS; ISFP Practice Committee. Fertility considerations in young women with hematological malignancies. J Assist Reprod Genet 2012;29:479-487.
40. Javid M, Magee TR, Galland RB. Arterial thrombosis associated with malignant disease. Eur J Vasc Endovasc Surg 2008;35:84-87.
41. Johnson LN, Dillon KE, Sammel MD, Efymow BL, Mainigi MA, Dokras A, Gracia CR. Response to ovarian stimulation in patients facing gonadotoxic therapy. Reprod Biomed Online 2013;26:337-344.
42. Khorana AA. Venous thromboembolism and prognosis in cancer. Thromb Res 2010; 125:490-493.
43. Khorana AA, Francis CW, Culakova E, Lyman GH. Risk factors for chemotherapyassociated venous thromboembolism in a prospective observational study. Cancer 2005;104:2822-2829.
44. Khorana AA, Francis CW, Culakova E, Fisher RI, Kuderer NM, Lyman GH. Thromboembolism in hospitalized neutropenic cancer patients. J Clin Oncol 2006; 24:484-490.
45. Khorana AA, Francis CW, Blumberg N, Culakova E, Refaai MA, Lyman GH. Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer. Arch Intern Med 2008;168:2377-2381.
46. Khorana AA, Streiff MB, Farge D, Mandala M, Debourdeau P, Cajfinger F, Marty M, Falanga A, Lyman GH. Venous thromboembolism prophylaxis and treatment in cancer: a consensus statement of major guidelines panels and call to action. J Clin Oncol 2009;27:4919-4926.
47. Khorana AA, Dalal M, Lin J, Connolly GC. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States. Cancer 2013;119:648-655.
48. Klock SC, Zhang JX, Kazer RR. Fertility preservation for female cancer patients: early clinical experience. Fertil Steril 2010;94:149-155.
49. Lidegaard Ø, Løkkegaard E, Jensen A, Skovlund CW, Keiding N. Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med 2012a; 366:2257-2266.
50. Lidegaard O, Nielsen LH, Skovlund CW, Løkkegaard E. Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10. BMJ 2012b; 344:e2990.
51. Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH, Quinn G, Wallace WH, Oktay K; American Society of Clinical Oncology. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2013;31:2500-2510.
52. Lyman GH, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP, Clarke JM, Flowers CR, Francis CW, Gates LE et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2013;31:2189-2204.
53. Mahmoodi BK, GansevoortRT, Næss IA, Lutsey PL, Brækkan SK, Veeger NJ, Brodin EE, Meijer K, Sang Y, Matsushita K et al. Association of mild to moderate chronic kidney disease with venous thromboembolism: pooled analysis of five prospective general population cohorts. Circulation 2012;126:1964-1971.
54. Meshksar A, Yadollahi Khales G, Borhani-Haghighi A. Middle cerebral artery infarction after in vitro fertilization: a case report. Int J Stroke 2013;8:E26.
55. Mmbaga N, Torrealday S, McCarthy S, Rackow BW. Acute portal vein thrombosis complicating in vitro fertilization. Fertil Steril 2012;98:1470-1473.
56. Mozes M, Bogokowsky H, Antebi E, Lunenfeld B, Rabau E, SerrDM,David A, Salomy M. Thromboembolic phenomena after ovarian stimulation with human gonadotrophins. Lancet 1965;2:1213-1215.
57. Nastri CO, Ferriani RA, Rocha IA, Martins WP. Ovarian hyperstimulation syndrome: pathophysiology and prevention. J Assist Reprod Genet 2010;27:121-128.
58. Nelson SM. Prophylaxis of VTE in women-during assisted reproductive techniques. Thromb Res 2009;123(Suppl 3):S8-S15.
59. Nelson SM. Venous thrombosis during assisted reproduction: novel risk reduction strategies. Thromb Res 2013;131(Suppl 1):S1-S3.
60. Previtali E, Bucciarelli P, Passamonti SM, Martinelli I. Risk factors for venous and arterial thrombosis. Blood Transfus 2011;9:120-138.
61. Rao AK, Chitkara U, Milki AA. Subclavian vein thrombosis following IVF and ovarian hyperstimulation: a case report. Hum Reprod 2005;20:3307-3312.
62. Raschi E, De Ponti F. Cardiovascular toxicity of anticancer-targeted therapy: emerging issues in the era of cardio-oncology. Intern Emerg Med 2012;7:113-131.
63. Reddy J, Oktay K. Ovarian stimulation and fertility preservation with the use of aromatase inhibitors in women with breast cancer. Fertil Steril 2012;98:1363-1369.
64. Rova K, Passmark H, Lindqvist PG. Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles. Fertil Steril 2012;97:95-100.
65. Salomon O, Schiby G, Heiman Z,Avivi K, Sigal C, Levran D, Dor J, Itzchak Y. Combined jugular and subclavian vein thrombosis following assisted reproductive technology- new observation. Fertil Steril 2009;92:620-625.
66. Scappaticci FA, Skillings JR, Holden SN, Gerber HP, Miller K, Kabbinavar F, Bergsland E, Ngai J, Holmgren E,Wang J et al. Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab. J Natl Cancer Inst 2007;99:2123-2129.
67. Seong SW, Park JH, Shin SK, Jin SA, Park YK, Choi SW. A case with upper extremity deep vein thrombosis after in vitro fertilization. J Cardiovasc Ultrasound 2010; 18:98-100.
68. Soares SR, Gómez R, Simón C, García-Velasco JA, Pellicer A. Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome. Hum Reprod Update 2008;14:321-333.
69. Stewart JA, Hamilton PJ, Murdoch AP. Thromboembolic disease associated with ovarian stimulation and assisted conception techniques. Hum Reprod 1997; 12:2167-2173.
70. Westerlund E, Henriksson P, Wallén H, Hovatta O, Wallberg KR, Antovic A. Detection of a procoagulable state during controlled ovarian hyperstimulation for in vitro fertilization with global assays of haemostasis. Thromb Res 2012;130:649-653.
71. Wun T, White RH. Epidemiology of cancer-related venous thromboembolism. Best Pract Res Clin Haematol 2009;22:9-23.
72. Yang D, Li J, Yuan Z, Liu X. Effect of hormone replacement therapy on cardiovascular outcomes: a meta-analysis of randomized controlled trials. PLoS One 2013; 8:e62329.
73. Zangari M, Fink LM, Elice F, Zhan F, Adcock DM, Tricot GJ. Thrombotic events in patients with cancer receiving antiangiogenesis agents. J Clin Oncol 2009; 27:4865-4873.